Calpain Inhibitor IV

Name: Calpain Inhibitor IV
Brand: Creative Peptides
SKU: C07006
Availability: MadeToOrder

Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

CAT No: C07006

CAS No: 133407-82-6

Synonyms/Alias: MG-132;133407-82-6;Z-Leu-leu-leu-al;MG132;MG 132;Zlllal;Z-Leu-leu-leucinal;Z-LLL-CHO;Zlll-cho;Z-Leu-Leu-Leu-H;Carbobenzoxy-leucyl-leucyl-leucinal;C26H41N3O5;Benzyloxycarbonylleucyl-leucyl-leucine aldehyde;Benzyloxycarbonyl-leu-leu-leu-aldehyde;Benzyloxycarbonyl-leucyl-leucyl-leucinal;Benzyl ((S)-4-methyl-1-(((S)-4-methyl-1-(((S)-4-methyl-1-oxopentan-2-yl)amino)-1-oxopentan-2-yl)amino)-1-oxopentan-2-yl)carbamate;Carbobenzoxyl-leucinyl-leucinyl-leucinal-H;Cbz-Leu-Leu-Leu-H;MFCD00674886;benzyl (S)-4-methyl-1-((S)-4-methyl-1-((S)-4-methyl-1-oxopentan-2-ylamino)-1-oxopentan-2-ylamino)-1-oxopentan-2-ylcarbamate;RF1P63GW3K;CHEMBL64925;N-[(Phenylmethoxy)carbonyl]-L-leucyl-N-[(1S)-1-formyl-3-methylbutyl]-L-leucinamide;Cbz-L-Leu-L-Leu-L-Leu-CHO;DTXSID3042639;CHEBI:75142;Lll cpd;(S)-N-((Phenylmethoxy)carbonyl)-L-leucyl-N-(1-formyl-3-methylbutyl)-L-leucinamide;N-[(Benzyloxy)carbonyl]-L-Leucyl-N-[(2s)-4-Methyl-1-Oxopentan-2-Yl]-L-Leucinamide;BRD0970;BRD-0970;Z-LLL;(S)-MG132;phenylmethyl N-[(2S)-4-methyl-1-[[(2S)-4-methyl-1-[[(2S)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamate;n-benzyloxycarbonyl-l-leucyl-l-leucyl-l-leucinal;1211877-36-9;UNII-RF1P63GW3K;Carbobenzoxy-L-leucyl-L-leucyl-L-leucinal;N-[(benzyloxy)carbonyl]-L-leucyl-N-[(1S)-1-formyl-3-methylbutyl]-L-leucinamide;zLLL;Benzyl N-[(1S)-3-methyl-1-[[(1S)-3-methyl-1-[[(2S)-4-methyl-1-oxo-pentan-2-yl]carbamoyl]butyl]carbamoyl]butyl]carbamate;phenylmethyl N-((2S)-4-methyl-1-(((2S)-4-methyl-1-(((2S)-4-methyl-1-oxopentan-2-yl)amino)-1-oxopentan-2-yl)amino)-1-oxopentan-2-yl)carbamate;Z-LLLal;Cbz-Leu-Leu-Leucinal;Z-LLL-H;Z-L-leu-L-leu-L-leu-H;BSPBio_001310;carbobenzoxy-Leu-Leu-leucinal;KBioGR_000030;KBioSS_000030;MLS006011220;Cbz-L-Leu-L-Leu-L-Leu-H;SCHEMBL160925;GTPL8616;DTXCID1022639;BCBcMAP01_000028;KBio2_000030;KBio2_002598;KBio2_005166;KBio3_000059;KBio3_000060;benzyloxycarbonyl-Leu-Leu-leucinal;Bio2_000030;Bio2_000510;GLXC-03835;HMS1361B12;HMS1791B12;HMS1989B12;HMS3402B12;EX-A1500;BDBM50069985;HB4135;NSC782153;PI-102;s2619;AKOS027420457;MG-132 [Z-Leu- Leu-Leu-CHO];CCG-207860;CCG-208036;CS-0471;FM29307;MG-132?;NSC-782153;compound 5b [PMID: 16686537];IDI1_033780;s10322;NCGC00161679-01;NCGC00161679-02;NCGC00161679-03;NCGC00161679-04;NCGC00161679-13;Z-Leu-Leu-Leu-al, >=90% (HPLC);AS-55854;benzyl N-[(1S)-3-methyl-1-{[(1S)-3-methyl-1-{[(2S)-4-methyl-1-oxopentan-2-yl]carbamoyl}butyl]carbamoyl}butyl]carbamate;HY-13259;SMR002530629;SW219780-1;UNM000011053701;Q3272916;SR-01000864598-1;BRD-K60230970-001-04-3;BRD-K60230970-001-05-0;BRD-K60230970-001-06-8;BRD-K60230970-001-07-6;BRD-K60230970-001-08-4;BRD-K60230970-001-10-0;BRD-K60230970-001-13-4;BRD-K60230970-001-16-7;BRD-K60230970-001-17-5;MG-132 - CAS 133407-82-6;MG-132, >/=95% by HPLC - CAS 133407-82-6;L-Leucinamide, N-((phenylmethoxy)carbonyl)-L-leucyl-N-((1S)-1-formyl-3-methylbutyl)-;L-Leucinamide, N-((phenylmethoxy)carbonyl)-L-leucyl-N-(1-formyl-3-methylbutyl)-, (S)-;L-Leucinamide, N-[(phenylmethoxy)carbonyl]-L-leucyl-N1-[(1S)-1-formyl-3-methylbutyl]-;(S)-4-methyl-2-(3-phenyl-propionylamino)-pentanoic acid [(S)-1-((S)-1-formyl-3-methyl-butylcarbamoyl)-3-methyl-butyl]-amide;{(S)-1-[(S)-1-((S)-1-Formyl-3-methyl-butylcarbamoyl)-3-methyl-butylcarbamoyl]-3-methyl-butyl}-carbamic acid benzyl ester;{1-[(S)-(S)-1-((S)-1-Formyl-3-methyl-butylcarbamoyl)-3-methyl-butylcarbamoyl]-3-methyl-butyl}-carbamic acid benzyl ester;{1-[1-(1-Formyl-3-methyl-butylcarbamoyl)-3-methyl-butylcarbamoyl]-3-methyl-butyl}-carbamic acid benzyl ester;849-040-8;benzyl N-[(1S)-1-[[(1S)-1-[[(1S)-1-formyl-3-methyl-butyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]carbamate;benzyl(S)-4-methyl-1-((S)-4-methyl-1-((S)-4-methyl-1-oxopentan-2-ylamino)-1-oxopentan-2-ylamino)-1-oxopentan-2-ylcarbamate;

Quick Inquiry Custom Peptide Synthesis

Deslorelin

Deslorelin is a gonadotropin releasing hormone super-agonist (GnRH agonist) also known as an LHRH agonist. It stops the production of sex hormones (testosterone and oestrogen). It is currently approved for use in veterinary medicine and is used to induce ovulation in mares as part of the artificial insemination process. It is also used to stabilize high-risk pregnancies, mainly of livestock. Unlike other GnRH agonists, which are mainly used to inhibit luteinizing hormone and follicle-stimulating hormone by their ultimate downregulation of the pituitary gland.

Inquiry
Angiotensin II

Angiotensin II human (Angiotensin II) is a vasoconstrictor that mainly acts on the AT1 receptor. Angiotensin II human stimulates sympathetic nervous stimulation, increases aldosterone biosynthesis and renal actions. Angiotensin II human induces growth of vascular smooth muscle cells, increases collagen type I and III synthesis in fibroblasts, leading to thickening of the vascular wall and myocardium, and fibrosis. Angiotensin II human also induces apoptosis.

Inquiry
Deslorelin Acetate

Deslorelin acetate is an injectable gonadotropin releasing hormone super-agonist (GnRH agonist) also known as an LHRH agonist. It stops the production of sex hormones (testosterone and oestrogen).

Inquiry
Glucagon

Glucagon (Porcine glucagon) is a peptide hormone, produced by pancreatic α-cells. Glucagon stimulates gluconeogenesis. Glucagon decreases the activity of HNF-4. Glucagon increases HNF4α phosphorylation.

Inquiry
Aviptadil Acetate

Aviptadil, also known as vasoactive intestinal polypeptide (VIP), is a 28 amino acid neuropeptide that belongs to the glucagon-growth hormone-releasing factor secretion superfamily. Aviptadil acts as a potent systemic vasodilator and bronchodilator. It inhibits the proliferation of vascular and bronchial smooth muscle cells and decreases platelet aggregation. These biological effects are mediated by specific VIP receptors.

Inquiry
DOTA-cyclo(RGDfK) acetate

Inquiry
GLP-1 (7-37) Acetate

Glucagon-like peptide-1 (GLP-1) is an incretin derived from the transcription product of the proglucagon gene. The major source of GLP-1 in the body is the intestinal L cell that secretes GLP-2 as a gut hormone.

Inquiry
Carbetocin

Carbetocin is a long-acting synthetic agonist analogue of human oxytocin, with antihemorrhagic and uterotonic activities. Upon administration, carbetocin targets, binds to and activates peripheral oxytocin receptors that are present on the smooth musculature of the uterus. This causes uterus contractions and prevents excessive bleeding after childbirth, particularly following Cesarean section, and may be used to decrease blood loss during hysteroscopic myomectomy.

Inquiry
GLP-1 (7-36) amide Acetate

Glucagon-like peptide-1 (GLP-1) is an incretin derived from the transcription product of the proglucagon gene. The major source of GLP-1 in the body is the intestinal L cell that secretes GLP-1 as a gut hormone. Its physiological functions include promoting insulin sensitivity, decreasing food intake by increasing satiety in brain and increasing insulin secretion from the pancreas in a glucose-dependent manner.

Inquiry
Teduglutide

Teduglutide is a polypeptide consisting of 33 amino acids. It is glucagon-like peptide-2 (GLP-2) analogue that is used for the treatment of short bowel syndrome.

Inquiry

M.F/Formula	C26H41N3O5
M.W/Mr.	475.6
Sequence	One Letter Code:LLL Three Letter Code:Cbz-Leu-Leu-Leu-al

InChI	InChI=1S/C26H41N3O5/c1-17(2)12-21(15-30)27-24(31)22(13-18(3)4)28-25(32)23(14-19(5)6)29-26(33)34-16-20-10-8-7-9-11-20/h7-11,15,17-19,21-23H,12-14,16H2,1-6H3,(H,27,31)(H,28,32)(H,29,33)/t21-,22-,23-/m0/s1
InChI Key	TZYWCYJVHRLUCT-VABKMULXSA-N